Impact of an interprofessional transition of care service on 30-day hospital reutilizations

Journal of Interprofessional Care
Shelley OtsukaDavid T Grande

Abstract

The objective of this study was to evaluate the impact of an interprofessional Transitions of Care (TOC) service on 30-day hospital reutilization inclusive of hospital readmissions and ED visits. This was a retrospective cohort study including patients discharged from an academic medical center between September 2013 and October 2014. Patients scheduled for a hospital follow-up visit in the post-acute care clinic (PACC) were included in the intervention group and patients without a post-discharge interprofessional TOC service were included in the comparison group. The intervention included a hospital follow-up visit with an interprofessional healthcare team. The primary composite outcome was hospital reutilization, defined as a hospital readmission or ED visit within 30 days of the discharge date. Overall, 330 patients were included in each group. In the intention-to-treat analysis, the primary composite outcome was not significantly different between groups (16.97% vs. 19.39%, P = 0.4195) whereas in the per-protocol analysis (all patients who showed to their PACC appointment), the primary outcome was significantly different in favor of the intervention group (9.28% vs. 19.39%, P = 0.0009). When components were analyzed separat...Continue Reading

References

Nov 2, 2006·American Journal of Public Health·Amy M KilbourneMichael J Fine
Feb 5, 2009·Annals of Internal Medicine·Brian W JackLarry Culpepper
Mar 15, 2012·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Suzanne Delbanco
Jun 27, 2012·Archives of Internal Medicine·Stephanie K MuellerJeffrey L Schnipper
Feb 27, 2013·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Thomas C BaileyMarin H Kollef
Apr 9, 2013·Annals of Emergency Medicine·Kristin L RisingAmy E Boutwell
Apr 2, 2014·Journal of General Internal Medicine·Jamie Jurkiewicz CavanaughShana Ratner
May 14, 2014·JAMA Internal Medicine·Aaron L LeppinVictor M Montori
Jul 16, 2014·Surgery·Sharon M Weber, Caprice C Greenberg
Jan 22, 2015·Circulation. Heart Failure·Nancy M AlbertUNKNOWN American Heart Association Complex Cardiovascular Patient and Family Care Committee of the Council on Cardiovascular and Str
May 21, 2015·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Matthew E ArnoldFekadu Fullas
Jan 23, 2016·Pharmacotherapy·Charmaine D Rochester-EyeguokanShirley J Reitz
Feb 26, 2016·The New England Journal of Medicine·Rachael B ZuckermanArnold M Epstein
Mar 10, 2016·JAMA Internal Medicine·Andrew D AuerbachJeffrey L Schnipper
Mar 11, 2016·North Carolina Medical Journal·Bill HitchCourtenay Gilmore Wilson
Sep 14, 2016·Hospital Pharmacy·Joseph TrangMinh-Tri Duong
Aug 9, 2017·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Chris CaraccioloJeremiah Brown
Sep 29, 2017·Journal of Interprofessional Care·Joyce YuT Joseph Mattingly

❮ Previous
Next ❯

Citations

Aug 21, 2020·Journal of Evaluation in Clinical Practice·Jennifer N SmithCorinne Rhodes
Feb 23, 2020·Journal of Interprofessional Care·Lindsey Merrihew HaddockRachel K Miller
Dec 11, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·William J HitchMackenzie Farrar
Jul 3, 2021·International Journal of Environmental Research and Public Health·Tinne DillesSue Jordan
Jan 5, 2022·Journal of Healthcare Management / American College of Healthcare Executives·Jason ZupecF Greg Lucado

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
Deanne T KashiwagiPrathibha Varkey
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Pamela M MoyeMaria Miller Thurston
© 2022 Meta ULC. All rights reserved